Last updated on September 2020

A Placebo-Controlled Study of the Safety of INCB054707 in Participants With Hidradenitis Suppurativa


Brief description of study

The purpose of this study is to evaluate the safety of INCB054707 over an 8-week treatment period in men and women with moderate to severe hidradenitis suppurativa.

Clinical Study Identifier: NCT03607487

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.